There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:A61K39/215
Jump to navigation
Jump to search
Pages in category "A61K39/215"
The following 17 pages are in this category, out of 17 total.
1
- 18251227. SIRNA-NANOBOWL-MEDIATED INTERVENTION OF COVID-19 simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18271366. MONOVALENT AND MULTIVALENT VACCINES FOR PREVENTION AND TREATMENT OF DISEASE simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18283042. Highly Attenuated Replication-Competent Recombinant Poxvirus As A Vaccine Platform And Methods Of Use simplified abstract (ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY)
- 18294912. Glycoengineered Foldon Domains and Related Compositions and Methods simplified abstract (The Regents of the University of California)
- 18629296. VACCINE ADJUVANTS, TRANSFECTION REAGENTS, AND METHODS OF USING THE SAME simplified abstract (WISCONSIN ALUMNI RESEARCH FOUNDATION)
- 18748995. NOVEL TREATMENT REGIMEN FOR THE TREATMENT OF AUTOIMMUNE DISORDERS simplified abstract (Merck Patent GmbH)
D
T
- The regents of the university of california (20240252619). Coronavirus Constructs and Vaccines simplified abstract
- The regents of the university of california (20240335523). Glycoengineered Foldon Domains and Related Compositions and Methods simplified abstract
- The Regents of the University of California patent applications on August 1st, 2024
- The Regents of the University of California patent applications on February 13th, 2025
- The Regents of the University of California patent applications on October 10th, 2024
